Massachusetts drug company to cut 65% of staff
Gene editing company Editas Medicine will reduce its workforce by 65% over the next six months as it focuses on in vivo CRISPR-edited medicines. On Dec. 12, the Cambridge, Mass.-based company said several leaders, including Chief Medical Officer Baisong …